# FDA recall D-1088-2014

> **Actavis** · Class III · drug recall initiated 2014-02-07.

## Product

Gelnique (oxybutynin chloride) Gel 10%, 100 mg in 1 g sachet, for topical use only.  Physician sample in clamshell container with seven heat-sealed sachets.  Rx Only.  Watson Pharmaceuticals Inc, Corona, CA, 92890.  NDC: 52544-084-77.

## Reason for recall

Subpotent Drug: Drug potency was compromised during shipment.

## Distribution

Distributed nationwide to physicians as samples.  No military/ govt/ VA or foreign consignees.

## Key facts

- **Recall number:** D-1088-2014
- **Recalling firm:** Actavis
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2014-02-07
- **Report date:** 2014-03-05
- **Termination date:** 2014-09-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Salt Lake City, UT, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1088-2014

## Citation

> AI Analytics. FDA recall D-1088-2014. Retrieved 2026-06-16 from https://api.ai-analytics.org/recall/D-1088-2014. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*